11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

#o

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/5/26 17:02
11/4/26
IDXXIdexx Laboratories Inc /DeDEHealthDiagnIn Vitro & In Vivo Diagnostic918S.d-97,937658.710-149166D
11/4/26 16:10
11/4/26
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo Diagnostic11S-11512.670-9-1000D
11/3/26 16:20
7/1/26
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic821S.dm-2,45610.340-2381,876D
9/8/26 16:51
9/3/26
CATXPerspective Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic24S.m-1,2653.130-40423,120D
8/21/26 16:30
8/19/26
ACHVAchieve Life Sciences, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic67S.d-1,2603.130-403896D
6/9/26 16:20
6/8/26
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo Diagnostic11S-674.460-15172D
2/2/26 20:51
1/30/26
IONSIonis Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo Diagnostic13S.d-4,80368.910-70133D
12/8/25 16:20
12/4/25
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic23S.d-1,32324.400-5456D
11/25/25 16:16
11/25/25
QDELQuidelortho CorpHealthDiagnIn Vitro & In Vivo Diagnostic11S.d-11227.810-437D
8/21/25 17:27
8/13/25
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic33S.m-382,59156.140-6,8157,063D
7/1/25 16:59
6/27/25
TKNOAlpha Teknova, Inc.DEHealthDiagnIn Vitro & In Vivo Diagnostic11S-415.060-812D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact